Analysis of risk factors for pre-diabetes to diabetes among cadres in Huzhou: a 5-year retrospective study
Abstract
Objective To analyze the risk factors of Diabetes Mellitus (DM) through a five-year retrospective study of prediabetes mellitus (Pre DM) cadres. Methods The cadres who underwent physical examination and were diagnosed as pre-diabetes in the First People's Hospital of Huzhou City from April 2019 to November 2024 were selected as the research objects, and their basic information (age, gender, body mass index, etc.), lifestyle (diet, exercise, smoking and drinking, etc.), family medical history, biochemical indicators (blood sugar, blood lipid, blood pressure, etc.) and other data were collected. People were divided into two groups according to whether they developed diabetes, and the risk factors of diabetes were determined by univariate analysis and multivariate Logistic regression analysis. Results A total of 174 pre-diabetic cadres were included, and 30 of them developed diabetes. Univariate analysis showed that there were differences in age, body mass index, fasting blood glucose, triglyceride, uric acid, blood pressure, blood lipid, liver function and lack of exercise of renal function between the two groups (P < 0.05). The results of multivariate Logistic regression analysis showed that age, BMI, SBP, TG, TC, BUN, TBIL and ALT were independent risk factors for the development of diabetes in pre-diabetic cadres' health care population within 5 years (P < 0.05). Conclusion This study shows that age, BMI, blood pressure, blood lipid level, liver and kidney function indexes and gender are important risk factors for PDM patients to develop into DM. Monitoring and managing these factors can reduce the risk of PDM patients progressing to DM. This provides personalized health management suggestions for PDM cadres and health care people, and also provides theoretical support for the formulation of relevant health policies.
Copyright (c) 2025 Yan Wu, Jun Yao, Shitong Xing, Ying Zhang, Yan Shen
This work is licensed under a Creative Commons Attribution 4.0 International License.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.